Several studies demonstrated that the administration of α-LA at a dose of 600 mg improved insulin sensitivity in patients with type 2 diabetes mellitus and cognitive functions in patients with Alzheimer's Disease [3,4,5,6]. Here, INS is linked to type 2 diabetes mellitus.